Aileron Therapeutics
Price & Volume
Stats
See more52W Range | $1.61-$7.42 |
Market Cap | $53.5M |
Shares Short | 233,272 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$17M |
Diluted EPS | -$2.88 |
News
See moreYahoo Finance • 2 years ago
Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
Yahoo Finance • 2 years ago
Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements
Yahoo Finance • 2 years ago
Aileron Therapeutics Announces a 1-for-20 Reverse Stock Split
Yahoo Finance • 2 years ago
Aileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
About
CEO | Dr. James Brian Windsor Ph.D. |
CFO | Mr. Timothy M. Cunningham CPA, M.B.A. |
Address | 12407 N. Mopac Expy., Austin, TX, United States, 78758 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |
